BIOBANK LPCE-NICE CHEST
|
|
|
- Brian Mitchell
- 8 years ago
- Views:
Transcription
1 BIOBANK LE-NIE HEST athologist : S. LASSALLE 01/03/2011 Time for frozen procedure : 10 mn LE / HU Unit atient : N LH N LB onsent : YES Age : 37 ID : TH ER Diagnosis and staging : Hodgkin s disease (nodular sclerosis) Diagnosis of frozen specimens : Hodgkin s disease 1- al tissue specimens Size : 1.4 cm Location : mediastinal lymph node 2- erilesional tissue specimens None Weights : D1 : 28 mg Weights : R1 : 38 mg, R2 : 15 mg, R3 : 8 mg, R4 : 18 mg ercent of tumor cells : 10 % 4- ontrols of quality For diagnosis bank : YES Not available Destock : erilesion
2 BIOBANK LE-NIE HEST athologist : V. HOFMAN 01/03/2011 Time for frozen procedure : 20 mn LE / HU Unit atient : N LH N LB onsent : YES Age : 65 ID : TR FR Diagnosis and staging : grade 3 invasive adenocarcinoma of the lung pt1anx Diagnosis of frozen specimens : grade 3 invasive adenocarcinoma 1- al tissue specimens Size : 0.7 cm Location : left lower lobe Weights : D1 : 53 mg 1R- Specimens for research : Nb : 3 Weights : R1 : 14 mg, R2 : 33 mg, R3 : 40 mg 2- erilesional tissue specimens Location : left lower lobe Histology : normal 2D- Specimens for diagnosis : Weights : D1 : 25 mg 2R- Specimens for research : Nb : 3 Weights : R1 : 30 mg, R2 : 29 mg, R3 : 16 mg ercent of tumor cells : 30 % 4- ontrols of quality For diagnosis bank : YES Destock : erilesion
3 BIOBANK LE-NIE HEST athologist : S. LASSALLE 01/04/2011 Time for frozen procedure : 10 mn LE / HU Unit atient : N LH N LB onsent : YES Age : 68 ID : SI YV Diagnosis and staging : mixed subtype adenocarcinoma (grade 3). pt4n0 Diagnosis of frozen specimens : mixed subtype adenocarcinoma 1- al tissue specimens Size : 3.5 cm Location : right upper lobe Weights : D1 : 91 mg Weights : R1 : 108 mg, R2 : 80 mg, R3 : 93 mg, R4 : 168 mg ercent of tumor cells : 60 % 2- erilesional tissue specimens Location : right upper lobe Histology : normal 2D- Specimens for diagnosis : Weights : D1 : 40 mg 2R- Specimens for research : Nb : 4 Weights : R1 : 70 mg, R2 : 69 mg, R3 : 36 mg, R4 : 50 mg 4- ontrols of quality For diagnosis bank : YES Destock : BioBank/2009-2/ x7 erilesion
4 BIOBANK LE-NIE HEST athologist : S. LASSALLE 01/04/2011 Time for frozen procedure : 20 mn LE / HU Unit atient : N LH N LB onsent : YES Age : 76 ID : MO JE Diagnosis and staging : squamous cell carcinoma (grade 3). pt1an1 Diagnosis of frozen specimens : squamous cell carcinoma 1- al tissue specimens Size : 2.2 cm Location : right upper lobe Weights : D1 : 43 mg Weights : R1 : 62 mg, R2 : 49 mg, R3 : 22 mg, R4 : 61mg ercent of tumor cells : 30 % 2- erilesional tissue specimens Location : right upper lobe Histology : mild emphysema 2D- Specimens for diagnosis : Weights : D1 : 67 mg 2R- Specimens for research : Nb : 4 Weights : R1 : 46 mg, R2 : 48 mg, R3 : 38 mg, R4 : 47 mg 4- ontrols of quality Destock : x6 erilesion
5 BIOBANK LE-NIE HEST athologist :. BUTORI 01/05/2011 Time for frozen procedure : 15 mn LE / HU Unit atient : N LH N LB onsent : NO Age : 49 ID : BE JE Diagnosis and staging : recidiving tracheal cystic adenoid carcinoma Diagnosis of frozen specimens : high grade cystic adenoid carcinoma 1- al tissue specimens Size : 0.5 to 1 cm 2- erilesional tissue specimens None Weights : D1 : 34.0 mg 1R- Specimens for research : Nb : 2 Weights : R1 : 26.0 mg, R2 : 42.0 mg ercent of tumor cells : 25 % 4- ontrols of quality Not available Destock : S erilesion
6 BIOBANK LE-NIE HEST athologist :. BUTORI 01/10/2011 Time for frozen procedure : 20 mn LE / HU Unit atient : N LH N LB onsent : YES Age : 57 ID : A GE Diagnosis and staging : colonic adenocarcinoma lung metastasis Diagnosis of frozen specimens : adenocarcinoma 1- al tissue specimens Size : 1.5 cm Location : left upper lobe Weights : D1 : 39 mg Weights : R1 : 76 mg, R2 : 90 mg, R3 : 65 mg, R4 : 124 mg ercent of tumor cells : 20 % 2- erilesional tissue specimens Location : peri tumoral Histology : alveolitis 2D- Specimens for diagnosis : Weights : D1 : 137 mg 2R- Specimens for research : Nb : 4 Weights : R1 : 81 mg, R2 : 104 mg, R3 : 93 mg, R4 : 64 mg 4- ontrols of quality Destock : erilesion
7 BIOBANK LE-NIE HEST athologist :. BUTORI 01/10/2011 Time for frozen procedure : 15 mn LE / HU Unit atient : N LH N LB onsent : YES Age : 65 ID : AK TO Diagnosis and staging : mixed sub type adenocarcinoma pt4nxm1 Diagnosis of frozen specimens : papillary and bronchiolo alveolar adenocarcinoma 1- al tissue specimens Size : 0.6 cm Location : right upper lobe 2- erilesional tissue specimens None Weights : D1 : not done (frozen in tissutek) ercent of tumor cells : 80 % 4- ontrols of quality For diagnosis bank : YES (tube D1): - : µg/µl ;Tot qty: 3.31µg - DO 260/280 : 1.92; R GADH : OK Not available Destock : BioBank/LM/ x7 erilesion
8 BIOBANK LE-NIE HEST athologist :. BUTORI 01/10/2011 Time for frozen procedure : 20 mn LE / HU Unit atient : N LH N LB onsent : YES Age : 66 Sex : F ID : BO MI Diagnosis and staging : small cell neuroendocrin carcinoma pleural metastasis Diagnosis of frozen specimens : small cell neuroendocrin carcinoma 1- al tissue specimens Size : 0.5 to 0.9 cm Location : parietal pleura 2- erilesional tissue specimens None Weights : D1 : 60 mg 1R- Specimens for research : Nb : 0 None ercent of tumor cells : 30 % 4- ontrols of quality Not available Destock : erilesion
9 BIOBANK LE-NIE HEST athologist : E. LONG 01/11/2011 Time for frozen procedure : 20 mn LE / HU Unit atient : N LH N LB onsent : YES Age : 68 ID : DO LU Diagnosis and staging : squamous cell carcinoma pt1anx Diagnosis of frozen specimens : squamous cell carcinoma 1- al tissue specimens Size : 2.2 cm Location : left upper lobe (peripheral) Weights : D1 : 78 mg Weights : R1 : 34 mg, R2 : 58 mg, R3 : 37 mg, R4 : 72 mg ercent of tumor cells : 50 % 2- erilesional tissue specimens Location : left upper lobe Histology : emphysema 2D- Specimens for diagnosis : Weights : D1 : 109 mg 2R- Specimens for research : Nb : 4 Weights : R1 : 113 mg, R2 : 38 mg, R3 : 37 mg, R4 : 58 mg 4- ontrols of quality Destock : erilesion
10 BIOBANK LE-NIE HEST athologist : E. LONG 01/11/2011 Time for frozen procedure : 20 mn LE / HU Unit atient : N LH N LB onsent : YES Age : 66 Sex : F ID : RA FR Diagnosis and staging : poorly differentiated thyroid vesicular adenocarcinoma (metastase) Diagnosis of frozen specimens : poorly differentiated thyroid vesicular adenocarcinoma (metastase) 1- al tissue specimens Size : 6 cm Location : left lower lobe 2- erilesional tissue specimens None Weights : D1 : 171 mg 1R- Specimens for research : Nb : 3 Weights : R1 : 190 mg, R2 : 213 mg, R3 : 313 mg ercent of tumor cells : 90 % 4- ontrols of quality Not available Destock : 7 x500µl erilesion
11 BIOBANK LE-NIE HEST athologist : V. HOFMAN 01/12/2011 Time for frozen procedure : 20 mn LE / HU Unit atient : N LH N LB onsent : NO Age : 53 ID : GA FR Diagnosis and staging : pleural metastasis by a lung adenocarcinoma. EGRF mutation research Diagnosis of frozen specimens : lung adenocarcinoma 1- al tissue specimens Size : biopsies Location : parietal pleura 2- erilesional tissue specimens None Weights : D1 : 92 mg 1R- Specimens for research : Nb : 0 ercent of tumor cells : 30 % 4- ontrols of quality For diagnosis bank : YES (tube D1): Tube1: - : µg/µl ;Tot qty: µg - DO 260/280 : 1.88; R GADH : OK Not available Destock : BioBank - LM erilesion
12 BIOBANK LE-NIE HEST LE / HU Unit athologist : S. LASSALLE 01/13/2011 lamp : 20 mn ; Frozen procedure : 57 mn ; T : 77 mn atient : N LH N LB onsent : YES Age : 71 ID : HO BE Diagnosis and staging : pleomorphic sarcomatoid carcinoma. pt3n2 Diagnosis of frozen specimens : pleomorphic sarcomatoid carcinoma 1- al tissue specimens Size : 2.5 cm Location : left power lobe Weights : D1 : 88mg Weights : R1 : 85mg, R2 : 58mg, R3 : 76mg, R4 : 110mg ercent of tumor cells : 90% 4- ontrols of quality RNA al (Tube R2) rrna 28S/18S: 1.7 RIN: 8.0 : µg/µl Tot qty : 67.3 µg 2- erilesional tissue specimens Location : left lower lobe Histology : normal 2D- Specimens for diagnosis : Weights : D1 : 90 mg 2R- Specimens for research : Nb : 4 Weights : R1 : 97 mg, R2 : 63 mg, R3 : 67 mg, R4 : 115 mg erilesional (Tube R2) rrna 28S/18S: 1.2 RIN: 6.9 : µg/µl Tot qty : 10.0 µg (Tube R2) : - : µg/µl ; Tot qty : 48.5 µg - DO 260/280 : 2.01 ; R GADH : OK erilesion (Tube R2) : - : µg/µl ; Tot qty : 14.0 µg - DO 260/280 : 1.89 ; R GADH : OK Destock : BioBank/ x500µl erilesion
13 BIOBANK LE-NIE HEST athologist : S. LASSALLE 01/13/2011 Time for frozen procedure : 20 mn LE / HU Unit atient : N LH N LB onsent : YES Age : 71 ID : E GE Diagnosis and staging : invasive epithelioid mesothelioma Diagnosis of frozen specimens : epithelioid mesothelioma 1- al tissue specimens Size : biopsies (unkown) Location : parietal pleura 2- erilesional tissue specimens None Weights : D1 : 27 mg Weights : R1 : 28 mg, R2 : 22 mg, R3 : 36 mg, R4 : 29 mg ercent of tumor cells : 40 % 4- ontrols of quality Not available Destock : A erilesion
14 BIOBANK LE-NIE HEST athologist : E. LONG 01/18/2011 LE / HU Unit atient : N LH N LB onsent : YES Age : 48 ID : A DO Diagnosis and staging : poorly differentiated pulmonary adenocarcinoma (metastase) Sex : F For diagnosis bank : YES Destock : 7 x500µl x 1
15 BIOBANK LE-NIE HEST athologist : V. HOFMAN 01/24/2011 Time for frozen procedure : 20 mn LE / HU Unit atient : N LH N LB onsent : YES Age : 75 ID : BO I Diagnosis and staging : lung metastasis by a colorectal adenocarcinoma Diagnosis of frozen specimens : lieberkhunien grade 1 adenocarcinoma 1- al tissue specimens Size : 1.5 x 1 cm Location : right lower lobe Weights : D1 : 49 mg Weights : R1 : 58 mg, R2 : 92 mg, R3 : 57 mg, R4 : 54 mg ercent of tumor cells : 50 % 2- erilesional tissue specimens Location : right lower lobe Histology : mild emphysema 2D- Specimens for diagnosis : Weights : D1 : 60 mg 2R- Specimens for research : Nb : 4 Weights : R1 : 66 mg, R2 : 61 mg, R3 : 59 mg, R4 : 65 mg 4- ontrols of quality Destock : erilesion
16 BIOBANK LE-NIE HEST LE / HU Unit athologist : E. LONG 01/25/2011 lamp : 20 mn ; Frozen procedure :28 mn ; T : 48 mn atient : N LH N LB onsent : YES Age : 64 ID : FU NO Diagnosis and staging : squamous cell carcinoma (keratinizing, grade 2) pt2an0 Diagnosis of frozen specimens : necrosis and fibrosis (should be verified on frozen section before DNA extraction) 1- al tissue specimens Size : 3cm Location : left upper lobe Weights : D1 : 47 mg Weights : R1 : 40 mg, R2 : 93 mg, R3 : 61 mg, R4 : 42 mg ercent of tumor cells : 5 % 2- erilesional tissue specimens Location : left upper lobe Histology : emphysema 2D- Specimens for diagnosis : Weights : D1 : 98 mg 2R- Specimens for research : Nb : 4 Weights : R1 : 135 mg, R2 : 30 mg, R3 : 84 mg, R4 : 81 mg 4- ontrols of quality Destock : BioBank/2009-2/ x500µL 1x100µL erilesion
17 BIOBANK LE-NIE HEST LE / HU Unit athologist :. BUTORI 01/26/2011 lamp : 8 mn ; Frozen procedure : 20 mn ; T : 28 mn atient : N LH N LB onsent : YES Age : 64 ID : DU JE Diagnosis and staging : epithelioid mesothelioma pt3n0 Diagnosis of frozen specimens : epithelioid mesothelioma 1- al tissue specimens Size : 15 cm Location : diffuse left pleura Weights : D1 : 208 mg Weights : R1 : 197 mg, R2 : 198 mg, R3 : 140 mg, R4 : 73 mg ercent of tumor cells : 70 % 2- erilesional tissue specimens Location : visceral pleura Histology : fibrosis 2D- Specimens for diagnosis : Weights : D1 : 122 mg 2R- Specimens for research : Nb : 4 Weights : R1 : 88 mg, R2 : 100 mg, R3 : 127 mg, R4 : 155 mg 4- ontrols of quality Destock : / x500µl erilesion
18 BIOBANK LE-NIE HEST athologist :. BUTORI 01/26/2011 LE / HU Unit atient : N LH N LB ID : BE MU onsent : YES Age : 58 Diagnosis and staging : broncho pulmonary adenocarcinoma pt4n0 For diagnosis bank : YES Destock : x7
19 BIOBANK LE-NIE HEST LE / HU Unit athologist : S. LASSALLE 01/27/2011 lamp : 10 mn ; Frozen procedure : 37 mn ; T : 47 mn atient : N LH N LB onsent : YES Age : 31 Sex : F ID : FA SA Diagnosis and staging : atypical carcinoid tumor pt1an0 Diagnosis of frozen specimens : atypical carcinoid tumor 1- al tissue specimens Size : 1.6 cm Location : right upper bronchus Weights : D1 : 47 mg Weights : R1 : 51 mg, R2 : 64 mg, R3 : 76 mg, R4 : 82 mg ercent of tumor cells : 70 % 2- erilesional tissue specimens Location : right upper lobe Histology : normal 2D- Specimens for diagnosis : Weights : D1 : 86 mg 2R- Specimens for research : Nb : 4 Weights : R1 : 17 mg, R2 : 73 mg, R3 : 87 mg, R4 : 104 mg 4- ontrols of quality Destock : x7 erilesion
20 BIOBANK LE-NIE HEST athologist :. BUTORI 01/31/2011 Time for frozen procedure : 20 mn LE / HU Unit atient : N LH N LB onsent : YES Age : 58 ID : FO MA Diagnosis and staging : Hodgkin lymphoma Diagnosis of frozen specimens : sclerosing nodular Hodgkin lymphoma 1- al tissue specimens Size : 0.4 to 1 cm Location : mediastinal 2- erilesional tissue specimens None Weights : D1 : 82 mg 1R- Specimens for research : Nb : 2 Weights : R1 : 141 mg, R2 : 91 mg ercent of tumor cells : 15 % 4- ontrols of quality Infection : YES (EBV) For diagnosis bank : YES Not available Destock : erilesion
21 BIOBANK LE-NIE HEST athologist :. BUTORI 01/26/2011 LE / HU Unit atient : N LH N LB onsent : YES Age : 63 ID : MA HU Diagnosis and staging : aspergillosis Sex : F Infection : YES (aspergillosis) Destock : x7
BIOBANK LPCE-NICE CHEST
HEST athologist :. BUTORI 08/01/2012 Time for frozen procedure : 45 mn LE / HU Unit atient : N LH 12-2304 N LB 12-0337 onsent : YES Age : 62 ID : MA H Diagnosis and staging : lung adenocarcinoma lymph
BIOBANK LPCE-NICE CHEST
BIOBANK LE-NIE HEST athologist :. BUTORI 12/09/2013 LE / HU Unit atient : N LH13-3603 N LB 13-0691 ID : RO A onsent : YES Age : 54 Diagnosis and staging : chronic pleuresia 5x1000µL BIOBANK LE-NIE HEST
Pathology of lung cancer
Pathology of lung cancer EASO COURSE ON LUNG CANCER AND MESOTHELIOMA DAMASCUS (SYRIA), MAY 3-4, 2007 Gérard ABADJIAN MD Pathologist Associate Professor, Saint Joseph University Pathology Dept. Hôtel-Dieu
Update on Mesothelioma
November 8, 2012 Update on Mesothelioma Intro incidence and nomenclature Update on Classification Diagnostic specimens Morphologic features Epithelioid Histology Biphasic Histology Immunohistochemical
YOUR LUNG CANCER PATHOLOGY REPORT
UNDERSTANDING YOUR LUNG CANCER PATHOLOGY REPORT 1-800-298-2436 LungCancerAlliance.org A GUIDE FOR THE PATIENT 1 CONTENTS What is a Pathology Report?...3 The Basics...4 Sections of a Pathology Report...7
Lung Cancer. Ossama Tawfik, MD, PhD Professor, Vice Chairman Director of Anatomic &Surgical Pathology University of Kansas School of Medicine
Lung Cancer Ossama Tawfik, MD, PhD Professor, Vice Chairman Director of Anatomic &Surgical Pathology University of Kansas School of Medicine Alexandria, Egypt July 1-1 3, 2008 OBJECTIVES Describe and
Neoplasms of the LUNG and PLEURA
Neoplasms of the LUNG and PLEURA 2015-2016 FCDS Educational Webcast Series Steven Peace, BS, CTR September 19, 2015 2015 Focus o Anatomy o SSS 2000 o MPH Rules o AJCC TNM 1 Case 1 Case Vignette HISTORY:
Primary -Benign - Malignant Secondary
TUMOURS OF THE LUNG Primary -Benign - Malignant Secondary The incidence of lung cancer has been increasing almost logarithmically and is now reaching epidemic levels. The overall cure rate is very low
Rare Thoracic Tumours
Rare Thoracic Tumours 1. Epithelial Tumour of Trachea 1 1.1 General Results Table 1. Epithelial Tumours of Trachea: Incidence, Trends, Survival Flemish Region 2001-2010 Both Sexes Incidence Trend EAPC
INTERNATIONAL ASSOCIATION FOR THE STUDY OF LUNG CANCER Prospective Mesothelioma Staging Project
INTERNATIONAL ASSOCIATION FOR THE STUDY OF LUNG CANCER Prospective Mesothelioma Staging Project Data Forms and Fields in CRAB Electronic Data Capture System - Reduced Set - Pivotal data elements for developing
The Diagnosis of Cancer in the Pathology Laboratory
The Diagnosis of Cancer in the Pathology Laboratory Dr Edward Sheffield Christmas Select 74 Meeting, Queen s Hotel Cheltenham, 3 rd December 2014 Agenda Overview of the pathology of cancer How specimens
Lung Carcinomas New 2015 WHO Classification. Spasenija Savic Pathology
Lung Carcinomas New 2015 WHO Classification Spasenija Savic Pathology ***EXPECTED SPRING 2015*** This authoritative, concise reference book provides an international standard for oncologists and pathologists
Changes in Breast Cancer Reports After Second Opinion. Dr. Vicente Marco Department of Pathology Hospital Quiron Barcelona. Spain
Changes in Breast Cancer Reports After Second Opinion Dr. Vicente Marco Department of Pathology Hospital Quiron Barcelona. Spain Second Opinion in Breast Pathology Usually requested when a patient is referred
Diagnosis of Mesothelioma Pitfalls and Practical Information
Diagnosis of Mesothelioma Pitfalls and Practical Information Mary Beth Beasley, M.D. Mt Sinai Medical Ctr Dept of Pathology One Gustave L Levy Place New York, NY 10029 (212) 241-5307 mbbeasleymd@yahoo.com
Recommendations for the Reporting of Pleural Mesothelioma
Recommendations for the Reporting of Pleural Mesothelioma Association of Directors of Anatomic and Surgical Pathology * DOI: 10.1309/6A30YQHBMTHEJTEM It has been evident for decades that pathology reports
Male. Female. Death rates from lung cancer in USA
Male Female Death rates from lung cancer in USA Smoking represents an interesting combination of an entrenched industry and a clearly drug-induced cancer Tobacco Use in the US, 1900-2000 5000 100 Per Capita
MALIGNANT MESOTHELIOMA UPDATE ON PATHOLOGY AND IMMUNOHISTOCHEMISTRY
MALIGNANT MESOTHELIOMA CLASSIFICATION MALIGNANT MESOTHELIOMA UPDATE ON PATHOLOGY AND IMMUNOHISTOCHEMISTRY Sisko Anttila, MD, PhD Jorvi Hospital Laboratory of Pathology Helsinki University Hospital Espoo,
This factsheet aims to outline the characteristics of some rare lung cancers, and highlight where each type of lung cancer may be different.
There are several different kinds of lung cancer, often referred to as lung cancer subtypes. Some of these occur more often than others. In this factsheet we will specifically look at the subtypes of cancers
INFLAMMATORY PLEURAL EFFUSION
PLEURA- LESIONS LESIONS OF PLEURA Primary Intra pleural bacterial infections Neoplasm (mesothelioma) Secondary A complication of some underlying disease PLEURAL EFFUSION Common manifestation of both primary
A 70-year old Man with Pleural Effusion
Mesothelioma Diagnosis: Pitfalls and Latest Updates S Klebe and DW Henderson Recommendations Indisputable malignant cells on cytomorphological criteria which demonstrate a mesothelial phenotype, which
MALIGNANT MESOTHELIOMA UPDATE ON PATHOLOGY AND IMMUNOHISTOCHEMISTRY
MALIGNANT MESOTHELIOMA UPDATE ON PATHOLOGY AND IMMUNOHISTOCHEMISTRY Sisko Anttila, MD, PhD Jorvi Hospital Laboratory of Pathology Helsinki University Hospital Espoo, Finland 2nd Nordic Conference on Applied
Diagnostic Challenge. Department of Pathology,
Cytology of Pleural Fluid as a Diagnostic Challenge Paavo Pääkkö,, MD, PhD Chief Physician and Head of the Department Department of Pathology, Oulu University Hospital,, Finland Oulu University Hospital
Extrapleural Pneumonectomy for Malignant Mesothelioma: Pro. Joon H. Lee 9/17/2012
Extrapleural Pneumonectomy for Malignant Mesothelioma: Pro Joon H. Lee 9/17/2012 Malignant Pleural Mesothelioma (Epidemiology) Incidence: 7/mil (Japan) to 40/mil (Australia) Attributed secondary to asbestos
Objectives. Mylene T. Truong, MD. Malignant Pleural Mesothelioma Background
Imaging of Pleural Tumors Mylene T. Truong, MD Imaging of Pleural Tumours Mylene T. Truong, M. D. University of Texas M.D. Anderson Cancer Center, Houston, TX Objectives To review tumors involving the
Frozen Section Diagnosis
Frozen Section Diagnosis Dr Catherine M Corbishley Honorary Consultant Histopathologist St George s Healthcare NHS Trust and lead examiner final FRCPath Practical 2008-2011 Frozen Section Diagnosis The
Lung Cancer: More than meets the eye
Lung Cancer Education Program November 23, 2013 Lung Cancer: More than meets the eye Shantanu Banerji MD, FRCPC Presenter Disclosure Faculty: Shantanu Banerji Relationships with commercial interests: Grants/Research
The National Clinical Lung Cancer Audit (LUCADA)
The National Clinical Lung Cancer Audit (LUCADA) DATA MANUAL Title: Version: 3.1.5 Date: September 2013 LUCADA Lung Cancer Audit VERSION HISTORY Version Date Issued Brief Summary of Change Owner s Name
Immunohistochemical differentiation of metastatic tumours
Immunohistochemical differentiation of metastatic tumours Dr Abi Wheal ST1. TERA 3/2/14 Key points from a review article written by Daisuke Nonaka Intro Metastatic disease is the initial presentation in
Cytology : first alert of mesothelioma? Professor B. Weynand, UCL Yvoir, Belgium
Cytology : first alert of mesothelioma? Professor B. Weynand, UCL Yvoir, Belgium Introduction 3 cavities with the same embryologic origin the mesoderme Pleura Exudates Pleura Peritoneum Pericardium 22%
9. Discuss guidelines for follow-up post-thyroidectomy for cancer (labs/tests) HH
9. Discuss guidelines for follow-up post-thyroidectomy for cancer (labs/tests) HH Differentiated thyroid cancer expresses the TSH receptor on the cell membrane and responds to TSH stimulation by increasing
Cardiac Masses and Tumors
Cardiac Masses and Tumors Question: What is the diagnosis? A. Aortic valve myxoma B. Papillary fibroelastoma C. Vegetation from Infective endocarditis D. Thrombus in transit E. None of the above Answer:
Plueral Malignancy: Radiologic-pathologic
Plueral Malignancy: Radiologic-pathologic Correlation Ritu R. Gill, MD Pleural Malignancies: Radiologic-Pathologic Correlation Ritu R Gill MD Brigham and Women s Hospital Boston, Massachusetts Pleural
PATHOLOGY OF THE PLEURA: Mesothelioma and mimickers Necessity of Immunohistochemistry. M. Praet
PATHOLOGY OF THE PLEURA: Mesothelioma and mimickers Necessity of Immunohistochemistry M. Praet Pathology of the Pleura Normal serosa: visceral and parietal layers Inflammation Neoplasia: Primary: mesothelioma
The develpemental origin of mesothelium
Mesothelioma Tallinn 14.12.06 Henrik Wolff Finnish Institute of Occupational Health The develpemental origin of mesothelium Mesodermal cavities (pleura, peritoneum and pericardium ) are lined with mesenchymal
Lung Cancer: Diagnosis, Staging and Treatment
PATIENT EDUCATION patienteducation.osumc.edu Lung Cancer: Diagnosis, Staging and Treatment Cancer begins in our cells. Cells are the building blocks of our tissues. Tissues make up the organs of the body.
PROTOCOL OF THE RITA DATA QUALITY STUDY
PROTOCOL OF THE RITA DATA QUALITY STUDY INTRODUCTION The RITA project is aimed at estimating the burden of rare malignant tumours in Italy using the population based cancer registries (CRs) data. One of
TUMORS OF THE TESTICULAR ADNEXA and SPERMATIC CORD
TUMORS OF THE TESTICULAR ADNEXA and SPERMATIC CORD Victor E. Reuter, MD Memorial Sloan-Kettering Cancer Center reuterv@mskcc.org 66 th Annual Pathology Seminar California Society of Pathologists Short
Pediatric Oncology for Otolaryngologists
Pediatric Oncology for Otolaryngologists Frederick S. Huang, M.D. Division of Hematology/Oncology Department of Pediatrics The University of Texas Medical Branch Grand Rounds Presentation to Department
General Information About Non-Small Cell Lung Cancer
General Information About Non-Small Cell Lung Cancer Non-small cell lung cancer is a disease in which malignant (cancer) cells form in the tissues of the lung. The lungs are a pair of cone-shaped breathing
Outline. Workup for metastatic breast cancer. Metastatic breast cancer
Metastatic breast cancer Immunostain Update: Diagnosis of metastatic breast carcinoma, emphasizing distinction from GYN primary 1/3 of breast cancer patients will show metastasis 1 st presentation or 20-30
Diseases. Inflammations Non-inflammatory pleural effusions Pneumothorax Tumours
Pleura Visceral pleura covers lungs and extends into fissures Parietal pleura limits mediastinum and covers dome of diaphragm and inner aspect of chest wall. Two layers between them (pleural cavity) contains
WORKPLACE SAFETY AND INSURANCE APPEALS TRIBUNAL DECISION NO. 1557/14
WORKPLACE SAFETY AND INSURANCE APPEALS TRIBUNAL DECISION NO. 1557/14 BEFORE: M. Crystal: Vice-Chair HEARING: August 20, 2014 at Toronto Written DATE OF DECISION: December 4, 2014 NEUTRAL CITATION: 2014
DELRAY MEDICAL CENTER. Cancer Program Annual Report
DELRAY MEDICAL CENTER Cancer Program Annual Report Cancer Statistical Data From 2010 TABLE OF CONTENTS Chairman s Report....3 Tumor Registry Statistical Report Summary...4-11 Lung Study.12-17 Definitions
Académie internationale de Pathologie - Division arabe XX ème congrès 24-26 novembre 2008 Alger. Immunohistochemistry in malignant mesotheliomas
Académie internationale de Pathologie - Division arabe XX ème congrès 24-26 novembre 2008 Alger Immunohistochemistry in malignant mesotheliomas Françoise Thivolet-Béjui Groupement Hospitalier Est Lyon-Bron
Oncology. Topic-Bile Duct Carcinoma. Topic-Adenocarcinoma, Lung. Topic-Hemangiosarcoma, Spleen and Liver
Topic-Adenocarcinoma, Lung Figure 1. Pulmonary adenocarcinoma. Figure 2. Pulmonary bronchiolar carcinoma. Figure 3. Pulmonary fibrosarcoma. Topic-Adenocarcinoma, Skin (Sweat Gland, Sebaceous) Figure 1.
Pleural and Pericardial fluids a one year analysis
Pleural and Pericardial fluids a one year analysis Dr Olafsdottir Dr J Williams Department of Cytology, Llandough Hospital Contents Background Standards Aims/Questions Investigation group Results Conclusions
September 2008 [KT 168] Sub. Code: 2063 M.D. DEGREE EXAMINATION Branch XVII Tuberculosis and Respiratory Diseases NON-TUBERCULOSIS CHEST DISEASES Common to Part II Paper II - (Old /New/Revised Regulations)
CASE OF THE MONTH AUGUST-2015 DR. GURUDUTT GUPTA HEAD HISTOPATHOLOGY
CASE OF THE MONTH AUGUST-2015 DR. GURUDUTT GUPTA HEAD HISTOPATHOLOGY CASE HISTORY 52Y MALE RIGHT RADICAL NEPHERECTOMY Case of right renal mass with IVC thrombus. History of surgery and RT for right occipital
Today s Topics. Tumors of the Peritoneum in Women
Today s Topics Tumors of the Peritoneum in Women Charles Zaloudek, M.D. Department of Pathology 505 Parnassus Ave., M563 University of California, San Francisco San Francisco, CA USA charles.zaloudek@ucsf.edu
The lungs What is lung cancer? How common is it? Risks & symptoms Diagnosis & treatment options
Why We re Here The lungs What is lung cancer? How common is it? Risks & symptoms Diagnosis & treatment options What Are Lungs? What Do They Do? 1 Located in the chest Allow you to breathe Provide oxygen
Locoregional & advanced esophagus or esophagogastric junction cancer
Eloxatin (oxaliplatin) Prior Authorization Request (For Maryland Only) Send completed form to: Case Review Unit CVS/caremark Specialty Programs Fax: 866-249-6155 CVS/caremark administers the prescription
Introduction: Tumor Swelling / new growth / mass. Two types of growth disorders: Non-Neoplastic. Secondary / adaptation due to other cause.
Disorders of Growth Introduction: Tumor Swelling / new growth / mass Two types of growth disorders: Non-Neoplastic Secondary / adaptation due to other cause. Neoplastic. Primary growth abnormality. Non-Neoplastic
General Rules SEER Summary Stage 2000. Objectives. What is Staging? 5/8/2014
General Rules SEER Summary Stage 2000 Linda Mulvihill Public Health Advisor NCRA Annual Meeting May 2014 National Center for Chronic Disease Prevention and Health Promotion Division of Cancer Prevention
How To Know When To Stage Lung Cancer
WHITE PAPER - SBRT for Non Small Cell Lung Cancer I. Introduction This white paper will focus on non-small cell lung carcinoma with sections one though six comprising a general review of lung cancer from
III II II 111111111111111111111111111111111111111111 1 1111111111111 III. ge: /ears sex: Male Access
UUID : 10F97F63 - EE6F-448D - 98E1-8AAA21F55753 TCGA - TS-A7PB-01A-PR Redacted III II II 111111111111111111111111111111111111111111 1 1111111111111 III Date Receive III 11111111111111111 11111111111 II
Case Report Predominantly Fibrous Malignant Mesothelioma in a Cat
SAGE-Hindawi Access to Research Volume 2010, Article ID 396794, 4 pages doi:10.4061/2010/396794 Case Report Predominantly Fibrous Malignant Mesothelioma in a Cat Alexander Th. A. Weiss, Afonso B. da Costa,
Notice of Faculty Disclosure
The Diagnosis of Malignant Mesothelioma Andrew Churg, MD Department of Pathology University of British Columbia Vancouver, BC, Canada achurg@mail.ubc.ca Notice of Faculty Disclosure In accordance with
About lung cancer. Contents. The lungs
This information is an extract from the booklet Understanding lung cancer. You may find the full booklet helpful. We can send you a free copy see page 7. The lungs Contents The lungs Types of lung cancer
Understanding Pleural Mesothelioma
Understanding Pleural Mesothelioma UHN Information for patients and families Read this booklet to learn about: What is pleural mesothelioma? What causes it? What are the symptoms? What tests are done to
How CanCer becomes critical in the claims
How CanCer becomes critical in the claims arena Cancer is a disease in which cells in your body grow in an uncontrolled way and form a lump called a tumour. In a healthy individual cells grow and reproduce
Malignant Lymphomas and Plasma Cell Myeloma
Malignant Lymphomas and Plasma Cell Myeloma Dr. Bruce F. Burns Dept. of Pathology and Lab Medicine Overview definitions - lymphoma lymphoproliferative disorder plasma cell myeloma pathogenesis - translocations
How To Write Lung Cancer Data Standards For Nhs Scotland
For reference only Do Not Use For more information contact: cdsis@nhs.net Lung Cancer Pathology Data Standards June 2008 National Clinical Dataset Development Programme (NCDDP) Support Team Information
Case based applications part III
Case based applications part III Los Angeles Society Of Pathologists January 25, 2014 Sanja Dacic, MD, PhD University of Pittsburgh Medical Center 1 CASE 1 A 44-year-old woman with multiple lung nodules.
CHAPTER 3: LUNG CANCER OVERVIEW
CHAPTER 3: LUNG CANCER OVERVIEW INTRODUCTION Learning about lung cancer is an important part of preparing for the decisions you will be making about your treatment and aftercare. The more you know about
بسم هللا الرحمن الرحيم
بسم هللا الرحمن الرحيم Updates in Mesothelioma By Samieh Amer, MD Professor of Cardiothoracic Surgery Faculty of Medicine, Cairo University History Wagner and his colleagues (1960) 33 cases of mesothelioma
Survival analysis of 220 patients with completely resected stage II non small cell lung cancer
窑 Original Article 窑 Chinese Journal of Cancer Survival analysis of 22 patients with completely resected stage II non small cell lung cancer Yun Dai,2,3, Xiao Dong Su,2,3, Hao Long,2,3, Peng Lin,2,3, Jian
Lung cancer. A guide for journalists on Non-Small Cell Lung Cancer (NSCLC) and its treatment
Lung cancer A guide for journalists on Non-Small Cell Lung Cancer (NSCLC) and its treatment Contents Contents 2 3 Section 1: Lung Cancer 4 i. Types of lung cancer 4 ii. Causes and risk factors 5 iii. Symptoms
Page 1 of 6 Origination Date: 08/13 Revision Date(s): 12/13, 12/14, 04/2015 Developed By: Medical Criteria Committee Effective Date: 10/1/2013
Moda Health Plan, Inc. Medical Necessity Criteria Subject: Alimta (pemetrexed) Page 1 of 6 Origination Date: 08/13 Revision Date(s): 12/13, 12/14, 04/2015 Developed By: Medical Criteria Committee Effective
Case Number: RT2009-124(M) Potential Audiences: Intent Doctor, Oncology Special Nurse, Resident Doctor
Renal Cell Carcinoma of the Left Kidney Post Radical Surgery with pt4 Classification with Multiple Lung and Single Brain Metastases: the Role and Treatment Consideration of Radiotherapy Case Number: RT2009-124(M)
Pleural Mesotheliomas in Sprague-D~wley Rats by Erionite: First Experimental Evidence
ENVIRONMENTAL RESEARCH 29, 238-244 (1982) Pleural Mesotheliomas in Sprague-D~wley Rats by Erionite: First Experimental Evidence CESARE MALTONI, FRANCO MINARDI, AND LEONILDO MORISI Institute oj Oncology,
THE PATHOLOGY OF MEDIASTINAL MASSES. Anatomic Distribution of Mediastinal Masses
Page 1 of 5 THE PATHOLOGY OF MEDIASTINAL MASSES Dr. S. Boag 549-6666 Ext. 4190, mailto:%20boag@cliff.path.queensu.ca 1. INTRODUCTION A wide range of process, neoplastic and non-neoplastic, can produce
More than 2,500 people are diagnosed with mesothelioma in the UK each year.
This information is an extract from the booklet Understanding mesothelioma. You may find the full booklet helpful. We can send you a free copy see page 5. Contents Introduction Pleural mesothelioma Peritoneal
Malignant Mesothelioma Diagnosed by Bronchoscopic Biopsy
CASE REPORT http://dx.doi.org/10.4046/trd.2015.78.3.297 ISSN: 1738-3536(Print)/2005-6184(Online) Tuberc Respir Dis 2015;78:297-301 Malignant Mesothelioma Diagnosed by Bronchoscopic Biopsy Yeon-Hee Park,
How To Treat Lung Cancer At Cleveland Clinic
Treatment Guide Lung Cancer Management The Chest Cancer Center at Cleveland Clinic, which includes specialists from the Respiratory Institute, Taussig Cancer Institute and Miller Family Heart & Vascular
The Ontario Cancer Registry moves to the 21 st Century
The Ontario Cancer Registry moves to the 21 st Century Rebuilding the OCR Public Health Ontario Grand Rounds Oct. 14, 2014 Diane Nishri, MSc Mary Jane King, MPH, CTR Outline 1. What is the Ontario Cancer
Avastin: Glossary of key terms
Avastin: Glossary of key terms Adenocarcinoma Adenoma Adjuvant therapy Angiogenesis Anti-angiogenics Antibody Antigen Avastin (bevacizumab) Benign A form of carcinoma that originates in glandular tissue.
General Thoracic Surgery ICD9 to ICD10 Crosswalks. C34.11 Malignant neoplasm of upper lobe, right bronchus or lung
ICD-9 Code ICD-9 Description ICD-10 Code ICD-10 Description 150.3 Malignant neoplasm of upper third of esophagus C15.3 Malignant neoplasm of upper third of esophagus 150.4 Malignant neoplasm of middle
What is Mesothelioma?
What is Mesothelioma? Mesothelioma is a rare type of cancer that develops in the mesothelial cells found in one s body. These cells form membranous linings that surround and protect the body s organs and
NEOPLASMS C00 D49. Presented by Jan Halloran CCS
NEOPLASMS C00 D49 Presented by Jan Halloran CCS 1 INTRODUCTION A neoplasm is a new or abnormal growth. In the ICD-10-CM classification system, neoplastic disease is classified in categories C00 through
CARCINOGENICITY TESTING OF ASBESTOS FIBRES - A PRELIMINARY STUDY
CARCINOGENICITY TESTING OF ASBESTOS FIBRES - A PRELIMINARY STUDY Extensive data is available on lung cancer and pleural mesothelioma caused by asbestos in man and animals. The object of the present work
Multiple Primary and Histology Site Specific Coding Rules KIDNEY. FLORIDA CANCER DATA SYSTEM MPH Kidney Site Specific Coding Rules
Multiple Primary and Histology Site Specific Coding Rules KIDNEY 1 Prerequisites 2 Completion of Multiple Primary and Histology General Coding Rules 3 There are many ways to view the Multiple l Primary/Histology
Standards and datasets for reporting cancers. Dataset for the histological reporting of mesothelioma. April 2013
Standards and datasets for reporting cancers Dataset for the histological reporting of mesothelioma April 2013 Authors Professor Andrew G Nicholson, Royal Brompton Hospital and Harefield NHS Trust Professor
Although many reports on the prognostic factors of non small cell
Carbone et al T2 tumors larger than five centimeters in diameter can be upgraded to T3 in non small cell lung cancer Emanuela Carbone, MD a,b Hisao Asamura, MD a Hidefumi Takei, MD a Haruhiko Kondo, MD
4 Good Tips Advocacy and Campaigns to Promote Cancer Care Li-Ying Chiu. Research and Development Specialist HOPE Foundation for Cancer Care
4 Good Tips Advocacy and Campaigns to Promote Cancer Care Li-Ying Chiu Research and Development Specialist HOPE Foundation for Cancer Care 1 Taiwan Area 36,000 km² Population : 23 million Coverage of NHI
POLICY A. INDICATIONS
Alimta (pemetrexed) Line(s) of Business: HMO; PPO; QUEST Integration Akamai Advantage Original Effective Date: 09/01/2007 Current Effective Date: 10/01/2015 POLICY A. INDICATIONS The indications below
THYROID CANCER. I. Introduction
THYROID CANCER I. Introduction There are over 11,000 new cases of thyroid cancer each year in the US. Females are more likely to have thyroid cancer than men by a ratio of 3:1, and it is more common in
Uses and Abuses of Pathology in Asbestos-exposed Populations
Uses and Abuses of Pathology in Asbestos-exposed Populations Jerrold L. Abraham, MD Department of Pathology State University of New York Upstate Medical University Syracuse, NY, 13210 USA The term: Asbestosis,
How To Diagnose And Treat A Tumour In An Effusion
Effusions of the Serous Cavities Annika Dejmek Professor/Consultant in Cytopathology Clinical Pathology; Department of Laboratory Medicine, Malmö, Lund University 5th EFCS Tutorial Trondheim 2012 Pleura
Medullary Renal Cell Carcinoma Case Report
Bahrain Medical Bulletin, Vol. 27, No. 4, December 2005 Medullary Renal Cell Carcinoma Case Report Mohammed Abdulla Al-Tantawi MBBCH, CABS* Abdul Amir Issa MBBCH, CABS*** Mohammed Abdulla MBBCH, CABS**
3-F. Pathology of Mesothelioma
3-F. Pathology of Mesothelioma Kouki Inai Professor of Department of Pathology, Graduate School of Biomedical Science, Hiroshima University Introduction Mesothelioma is a peculiar type of malignancy, which
Rilevanza dell innovazione tecnologica per la
Rilevanza dell innovazione tecnologica per la ricerca traslazionale e la terapia in oncologia Ruggero De Maria Dipartimento di Ematologia Oncologia e Medicina Molecolare, Istituto Superiore di Sanità Translational
Lung Cancer Screening Registry
The American College of Radiology Lung Cancer Screening Registry (LCSR) Data Dictionary May 13, 2016 American College of Radiology 1891 Preston White Drive Reston, VA 20191-4397 Copyright 2014, American
A Practical Guide to Advances in Staging and Treatment of NSCLC
A Practical Guide to Advances in Staging and Treatment of NSCLC Robert J. Korst, M.D. Director, Thoracic Surgery Medical Director, The Blumenthal Cancer Center The Valley Hospital Objectives Revised staging
FNA Cytology of Mediastinal Lesions. Presenters: Xiaoqi Lin, M.D., Ph.D. Ritu Nayar, M.D.
Disclosure information The speakers have no relationship that represents a possible conflict of interest with respect to the content of this presentation. FNA Cytology of Mediastinal Lesions Presenters:
Cancer of the Cardia/GE Junction: Surgical Options
Cancer of the Cardia/GE Junction: Surgical Options Michael A Smith, MD Associate Chief Thoracic Surgery Center for Thoracic Disease St Joseph s Hospital and Medical Center Phoenix, AZ Michael Smith, MD
Non-Small Cell Lung Cancer
Non-Small Cell Lung Cancer About Your Lungs and Lung Cancer How do your lungs work? To understand lung cancer it is helpful to understand your lungs. Your lungs put oxygen into the blood, which the heart
Multiple Primary and Histology Coding Rules
Multiple Primary and Histology Coding Rules January 10, 2008 National Cancer Institute Surveillance Epidemiology and End Results Program Bethesda, MD PLEASE NOTE This PDF of the 2007 Multiple Primaries
CT findings in Differential Diagnosis between Tuberculous Pleurisy and Malignant Effusion
CT findings in Differential Diagnosis between Tuberculous Pleurisy and Malignant Effusion Poster No.: E-0084 Congress: ESTI 2012 Type: Scientific Exhibit Authors: S. S. Shim, Y. Kim; Seoul/KR Keywords:
Round Table with Drs. Anne Tsao and Alex Farivar, Case 2: Mesothelioma
Round Table with Drs. Anne Tsao and Alex Farivar, Case 2: Mesothelioma I d like to welcome everyone, thanks for coming out to our lunch with experts. The faculty today are great people in the thoracic